We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Harmonic Inc
HLIT
$1.36B
| $52K | ﹤0.01% |
+7,068
| New | +$46.5K |
|
|
IPG
427
DELISTED
Interpublic Group of Companies
IPG
| $52K | ﹤0.01% |
+2,220
| New | +$46.6K |
|
428
Labcorp
LH
$25.1B
| $52K | ﹤0.01% |
+299
| New | +$51.6K |
|
429
Microchip Technology
MCHP
$43.7B
| $52K | ﹤0.01% |
+754
| New | +$46.9K |
|
430
Medifast
MED
$148M
| $52K | ﹤0.01% |
+267
| New | +$47.2K |
|
431
Pricesmart
PSMT
$6.05B
| $52K | ﹤0.01% |
+566
| New | +$44.5K |
|
432
Robert Half
RHI
$4.07B
| $52K | ﹤0.01% |
+836
| New | +$49.9K |
|
433
TTM Technologies
TTMI
$14.1B
| $52K | ﹤0.01% |
+3,741
| New | +$47.8K |
|
434
Universal Insurance Holdings
UVE
$1.23B
| $52K | ﹤0.01% |
+3,433
| New | +$48.4K |
|
|
XLNX
435
DELISTED
Xilinx Inc
XLNX
| $52K | ﹤0.01% |
+367
| New | +$47.7K |
|
436
CDW
CDW
$19.2B
| $51K | ﹤0.01% |
+384
| New | +$50.3K |
|
437
Quest Diagnostics
DGX
$25.8B
| $51K | ﹤0.01% |
+431
| New | +$52.5K |
|
438
HCI Group
HCI
$2.3B
| $51K | ﹤0.01% |
+972
| New | +$49.1K |
|
439
Omnicom Group
OMC
$22.1B
| $51K | ﹤0.01% |
+823
| New | +$47K |
|
440
Tractor Supply
TSCO
$17.3B
| $51K | ﹤0.01% |
+1,820
| New | +$50.9K |
|
441
United Natural Foods
UNFI
$2.94B
| $51K | ﹤0.01% |
+3,181
| New | +$53.2K |
|
442
Winnebago Industries
WGO
$898M
| $51K | ﹤0.01% |
+844
| New | +$46K |
|
443
Digi International
DGII
$2.77B
| $50K | ﹤0.01% |
+2,644
| New | +$45.3K |
|
444
Fastenal
FAST
$56.7B
| $50K | ﹤0.01% |
+2,052
| New | +$48.3K |
|
445
W.W. Grainger
GWW
$61.8B
| $50K | ﹤0.01% |
+122
| New | +$48K |
|
446
El Pollo Loco
LOCO
$504M
| $50K | ﹤0.01% |
+2,783
| New | +$46.8K |
|
447
Perdoceo Education
PRDO
$2.06B
| $50K | ﹤0.01% |
+3,920
| New | +$47.1K |
|
448
Safety Insurance
SAFT
$1.51B
| $50K | ﹤0.01% |
+640
| New | +$46.9K |
|
449
SPS Commerce
SPSC
$2.67B
| $50K | ﹤0.01% |
+457
| New | +$42.9K |
|
450
United Rentals
URI
$71.5B
| $50K | ﹤0.01% |
+217
| New | +$45.8K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.